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Complexes of luteinizing hormone releasing hormone (LHRH) with divalent metal ions (Ni,
Zn, Cu) have been studied by matrix-assisted laser desorption ionization (MALDI) and Fourier
transform mass spectrometry. LHRH–metal complexes were detected in high abundance for
all three metals from synthesized samples, particularly in negative ion mode. The mixture of
the apopeptide with the metal salts yielded in most cases a very minor signal of metal–
complex ions. As opposed to Ni and Zn, copper complex ions were mostly observed as Cu(I)
adducts. This can be partly attributed to plume reactions of Cu(I) with the apopeptide. the
Cu(II) complexes appeared only for the synthetic complex. We show how to distinguish
between the contribution to the overall signal from desorbed complexes and from Cu(I)
complexes formed in the MALDI plume. (J Am Soc Mass Spectrom 1999, 10, 19–26) © 1999
American Society for Mass Spectrometry
Transition metal ions are known to affect a numberof biological processes by altering peptide orprotein structures. The binding of metal ions
reduces the number of accessible conformations and,
hence, the conformational entropy. Metal binding is
thus very effective for inducing secondary structures in
smaller proteins [1].
Electrospray ionization (ESI) and matrix-assisted la-
ser desorption/ionization (MALDI) are soft ionization
techniques which are typically used for peptide and
protein analysis by mass spectrometry. ESI has gained
wide acceptance as a tool for the analysis of noncova-
lent complexes [2]. The observation of coordinate-cova-
lent and noncovalent binding complexes has been far
more elusive by MALDI-MS and work is needed on
model compounds in order to get more information
about the reliability of the technique for such investiga-
tions [3].
Luliberin (luteinizing hormone releasing hormone,
LHRH) is a decapeptide amide of the sequence
pGlu–His–Trp–Ser–Tyr–Gly–Leu–Arg–Pro–Gly–NH2.
The best known action of this brain hormone is the
induction of luteinizing hormone (LH) and follicle
stimulation hormone (FSH) release from the hypoph-
ysis. In vivo studies have shown that the metal
complexes of the hormone have different biological
activities than the free hormone. For instance, metal
complexes of LHRH inhibit ovulation, but increase
the release of LH and FSH [4, 5]. LHRH was chosen as
a model compound because of its affinity for Cu(II),
Ni(II), and Zn(II) metal ions in solution has been
measured and because there are reliable methods to
synthesize the metal complexes of the peptide.
Gerega et al. [6] have studied the complexation of
Cu(II) and Ni(II) with LHRH in solution by means of
electron spin resonance, ultraviolet spectroscopy, circu-
lar dichroism, and potentiometry. They have demon-
strated that the primary binding site for the metal ion
was the imidazole nitrogen (Nim) of the histidine resi-
due. In solution at pH between 5.5 and 9.5, Cu forms a
3N complex by simultaneous deprotonation of two
amide nitrogens: the NH from the amide bond between
His and pGlu, and the NH from the pGlu. Ni forms
mainly a 1N complex between pH 5 and 7.5 with a
coordination to the Nim of the His (and possibly to
carbonyl oxygens). At higher pH, Ni promotes depro-
tonation of up to three amide nitrogens towards the C
terminal. Bal et al. [7] have studied the complexation
behavior of LHRH with Zn in solution by potentiomet-
ric methods and NMR. The complexes formed are less
stable than for Cu and Ni, and no deprotonation of
amide nitrogens occur. The Zn is coordinated to the Nim
of the His residue and to the carbonyl oxygen of the
His–Trp bond. From these studies, the affinity of LHRH
for the metal ions in aqueous solution follows the order
Cu . Ni . Zn.
Another interesting feature of this peptide is that its
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N terminal is blocked (pyroglutamic acid) and its C
terminal amidated, thus reducing its ability to react
with divalent metal ions in the gas phase [8].
In MALDI, the analysis of metal ion complexes can
be complicated by the appearance of artifactual adduct
species originating from ion–molecule reactions in the
MALDI plume. In most MALDI studies of metal–
peptide complexation reported so far, samples were
prepared by mixing the apopeptide (or apoprotein)
solution with a solution of the metal salt. In many cases,
in order to displace the association equilibrium, a large
excess of metal was used [9]. However, even if some
intact peptide–metal complex precipitates, the high salt
content of the samples deteriorates the MALDI signal
and may favor cationization in the plume rather than
direct desorption of the complex.
Some authors have suggested the use of nonacidic
matrices in order to avoid dissociation of the metal–
peptide complexes during sample preparation [10].
Using this approach, they have been able to observe
both noncovalent metal-binding and peptide–enzyme
complexes. Such matrices were also used for probing
other noncovalent associations by MALDI and yielded
good results [11, 12].
In the present work, we compare the MALDI spectra
of synthetic Cu, Ni, and Zn complexes of LHRH and of
mixtures between the peptide and metal salts. If plume
reactions were the major source of the metal-containing
ions observed, the two methods should give identical
results because the metal:peptide ratio was kept con-
stant in all experiments. However, as detailed below,
the two approaches gave very different results. Analy-
ses of a mixture of LHRH with a silver salt, as well as
competition experiments were also carried out, in order
to further distinguish nonspecific adduct formation in
the MALDI plume from the desorption of preformed
complex ions.
For the present study, a mass resolution greater than
2000 at m/z ' 1300 was required to resolve the isotopic
patterns. Although this resolution can be attained with
new generation time-of-flight (TOF) instruments
equipped with delayed extraction and reflectrons, it is
out of reach with classical TOF instruments. Fourier
transform mass spectrometry (FTMS) is very well
suited for such studies because a resolution of 10,000 or
above is routinely achieved. Moreover, good mass
precision, another feature of FTMS, is necessary for
unambiguous determination of the oxidation state of
the metal in the complex ions.
Experimental
Materials
LHRH was obtained from Sigma (Buchs, Switzerland)
and used without purification. Paranitroaniline (PNA)
was also obtained from Sigma. It was recrystallized
from hot ethanol solution by slow cooling after addition
of boiling water. Metal salts Cu(NO3)2, CuCl2,
Cu(CH3COO)2, NiCl2, and ZnCl2 were purchased from
Fluka (Buchs, Switzerland); CF3COOAg and Ni(NO3)2
were obtained from Aldrich (Buchs, Switzerland).
Synthesis of LHRH–Metal Complexes
LHRH–metal complexes were synthesized according to
published procedures [4]. LHRH–Ni(II) and LHRH–
Zn(II) complexes were obtained by mixing an ethanol
solution of LHRH with freshly precipitated Ni(OH)2 or
Zn(OH)2. LHRH–Cu(II) was prepared by fusion of
ethanol solutions of the peptide and of copper dode-
canoate. The ethanol was vacuum evaporated, and the
residue was dissolved in water, extracted with chloro-
form, and the aqueous layer vacuum evaporated. The
copper dodecanoate was prepared from copper acetate
according to the procedure described by Seddon et al.
[13].
MALDI Sample Preparations
Two different preparations were used throughout this
work. In the first set of experiments, the metal com-
plexes of LHRH were prepared either as suspensions
(Ni and Zn, ; 1026 mol of complex per mL of solvent
after sonication) or solutions (Cu, 1023 M) in ethanol. 5
mL were mixed with 3 mL of a PNA solution in ethanol
(10 mg/mL), deposited on the probe tip, and air dried.
In the other set of experiments, 5 mL of an apopeptide
solution in water (1023 M) was mixed with 5 mL of an
aqueous metal salt solution (0.01 M). 6 mL of an ethan-
olic PNA solution (10 mg/mL) were added, 10 mL of the
final mixture were deposited on the probe tip, and the
sample was air dried. Using the latter procedure, the
metal and the peptide should associate to some extent
in the solution. The presence of the apopeptide and free
metal is however very likely. The peptide-to-metal
molar ratio was always set to 1:1. The laser pulse energy
was adjusted just above threshold for ion production
(estimated irradiance on the sample between 2 and 5 3
106 W cm22).
Mass Spectrometry
All experiments were performed on a homemade FTMS
with an elongated cylindrical cell. the instrument is
equipped with a 4.7 tesla magnet (Bruker, Bremen,
Germany) and Odyssey acquisition electronics (Finni-
gan, Madison, WI). A Nd:YAG laster operated at 355
nm (Minilite ML-10, Continuum, Santa Clara, CA)
whose beam was collinear with the axis of the cell (laser
incidence angle 5 90°) was used for desorption / ion-
ization. The energy on the sample was controlled via
the variation of the delay between the flash lamps and
the Q-switch. The maximum output energy of the laser
is 4 mJ at a Q-switch delay of 200 ms. Following
ionization, the ions were allowed to drift inside the
trapping cell by using the gated trapping technique (0
3 9 V). After 120 ms, the trapping voltage was set to its
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nominal value (61 V). A 100-ms delay followed, after
which the ions were excited by a radio-frequency chirp.
Detection was then accomplished at an acquisition rate
of 400 kHz using 128 KB of memory. The resulting
transient was apodized (Blackman–Harris 3 terms [14])
and zero filled twice before Fourier transform to pro-
duce a mass spectrum.
Results and Discussion
For each metal ion (Cu, Zn, and Ni), we compared the
MALDI mass spectra of the synthesized complex
(LHRH–metal) and of the mixture of the metal salt with
the apopeptide. PNA was chosen as a matrix because of
its low acidity in order to preserve the complexes
[10–12, 15]. Similar experiments done with 2,5-dihy-
droxybenzoic acid (pKa 5 2.97) failed to yield complex
ions in most cases.
Table 1 summarizes the results obtained in positive
and negative ion mode. The observed signals support
the hypothesis that direct desorption of preformed
species occurs to a significant extent in the case of the
synthesized complexes. The results obtained for Ni
and Zn are very similar and they differ from those
obtained for Cu. Therefore, we will discuss copper
separately.
Experiments with Ni and Zn
LHRH–Ni and Zn complexes Figure 1 shows the posi-
tive and negative ion spectra of the LHRH–Ni complex.
These results are also representative for the synthesized
LHRH–Zn complex.
In positive mode (Figure 1a), the main ion detected is
the protonated peptide [M 1 H]1. As the complex
should be deposited intact on the probe and there
should be little or no free peptide nor free metal
remaining, this species must result from the fragmen-
tation of the complex. It is obvious that in positive ion
Table 1. Summary of the principal species observed for the MALDI/FTMS of LHRH, LHRH–metal complexes, and mixtures of
LHRH with metal salts in PNA. M 5 LHRH, R 5 CH2O. The [y8 1 Ni] signal has a relative intensity of only 2.5%
Sample
Positive ions Negative ions
Base peak
Most abundant metal
containing species Other species Base peak
Most abundant metal
containing species Other species
LHRH [M 1 H] [M 2 H 2 R] [M 2 H]
LHRH–Cu
complex
[M 1 Cu] [M 1 Cu] [M 1 H]
[M 1 Na]
[M 2 2H 1 Cu]
[M 1 Cu 2 H 1 Na]
[M 2 2H 1 Cu(I)]
[M 2 3H 1 Cu(II)]
[M 2 H 2 R]
[M 2 2H 1 Cu(I) 2 R]
[M 2 3H 1 2Cu(I)]
[M 2 4H 1 Cu(II) 1 Cu(I)]
LHRH and
CuCl2
[M 1 H] [M 1 Cu] [M 2 H 2 R] [M 2 2H 1 Cu(I)] [M 2 H]
[M 2 2H 1 Cu(I) 2 R]
LHRH–Ni
complex
[M 1 H] [y8 1 Ni] [M 2 H 1 Ni] [M 2 3H 1 Ni] [M 2 3H 1 Ni] [M 2 H 2 R]
[M 2 5H 1 2Ni]
LHRH and
NiCl2
[M 1 H] [y8 1 Ni](trace) [M 2 H 2 R] [M 2 3H 1 Ni] [M 2 H]
LHRH–Zn
complex
[M 1 H] [z7 2 3H 1 Zn] [M 2 H 1 Zn] [M 2 3H 1 Zn] [M 2 3H 1 Zn] [M 2 H 2 R]
[M 2 5H 1 2Zn]
LHRH and
ZnCl2
[M 1 H] Not detected [M 2 H 2 R] [M 2 3H 1 Zn] [M 2 H]
Figure 1. MALDI FTMS spectra of the LHRH–Ni complex in
positive (a) and negative (b) ion modes.
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mode, the Ni and Zn complexes of LHRH fragment
quite extensively during the MALDI process. The peaks
corresponding to the complexed LHRH [M 2 H 1
Ni(II)]1 or [M 2 H 1 Zn(II)]1 are observed with low
abundance. For both metals, a fragment which contains
one metal atom was detected. For the Ni complex, this
fragment was observed at m/z 990 and was assigned to
[y8 1 Ni]
1. This fragment corresponds to the loss of the
N terminal pGlu–His fragment of the peptide. It can be
related to the classical C-terminal [yn 1 2H]
1 fragments
which typically arise from protonated peptides even
though this was not observed in the case of the apopep-
tide (data not shown). The Ni ion is known to be
primarily coordinated to the imidazole nitrogen of the
histidine [6] and thus is losing its primary coordination
site upon formation of [y8 1 Ni]
1. The conservation of
the metal on the fragment can be explained by the fact
that Ni can also coordinate to deprotonated amide
nitrogens closer to the C terminal. In the case of Zn, a
different fragment appeared at m/z 792 which was
tentatively attributed to [z7 2 3H 1 Zn]
1. This is more
unusual fragmentation and we have not been able to
find a rational explanation for its occurrence.
In negative mode (Figure 1b), ions corresponding to
[M 2 3H 1 Ni(II)]2 and [M 2 3H 1 Zn(II)]2 are de-
tected as the base peak. The deprotonated peptide and
the fragment at m/z 1150 [M 2 H 2 CH2O]
2 showed
up with much lower intensity. The presence of peaks
containing two metal atoms can results either from gas
phase reactions, or from the desorption and subsequent
fragmentation of higher order aggregates present in the
solid sample.
The higher relative abundance of anions containing
the nickel, compared to the analogous cationic signals,
can be explained by the intrinsic gas-phase acidity of
the amide NH which is similar to that of the carboxylic
acid OH [16]. Therefore, as Ni favors the deprotonation
of the amide nitrogen in solution, it must proceed easily
with the desorption of the complex. In the case of Zn
however, the deprotonation of amide nitrogen does not
occur in solution [6]. Based on our observation of a
triply deprotonated LHRH–Zn complex, we conclude
that this process can occur in the gas phase.
Negatively charged peptide metal complexes have
been observed by other groups by fast atom bombard-
ment (FAB) of alkaline earth or transition metal ions
and tripeptides [8, 17, 18]. These authors stated that the
negative ions which are preformed in solution may be
easily desorbed. Moreover, they reported that whereas
alkaline earth metal ions in solution do not form com-
plexes in which the amide NH groups are deproto-
nated, they produce triply deprotonated anions by FAB
[8]. We observed the same behavior for LHRH–Zn
complex anions by MALDI. These anions are expected
to be observed with high relative intensity compared to
their positive counterparts because the deprotonation of
amide nitrogens allows an increase in the coordination
number of the metal.
Whereas many differences between positive and
negative ion data can be attributed to stability, at least
some may be under kinetic control. In addition, as
evident from the signal-to-noise ratios, the relative
intensities of anionic complexes are generally lower
than those of the cationic species. This implies that in
some instances the anionic complexes may be more
stable than other possible anions (thus dominating
negative ion spectra) while still being less stable
(and/or less abundant) than the corresponding cations
on an absolute scale.
Mixture of metal salt and peptide When a mixture of
LHRH with NiCl2 or ZnCl2 in PNA was applied to the
probe tip, the protonated peptide ion was the major
species observed in positive mode, whereas its frag-
ment [M 2 H 2 CH2O]
2 was the main detected nega-
tive ion (see Figure 2). A minor signal arising from
metal complexes, in both positive and negative ion
modes, was detected. this signal was always much
lower than the ones from the apopeptide-related species
even when a 10-fold molar excess of metal salt was
added.
The detected complex ions may originate from direct
desorption of “preformed complexes” or from associa-
tions in the plume. The peptide-to-metal ratio was kept
the same (1:1) in the experiments with the mixture and
with the synthetic complex, thus the contributions from
plume reactions should be very similar or identical. If
we suppose that in the case of the mixture, all complex
ions are formed via plume reactions, we must consider
Figure 2. MALDI FTMS spectra of a mixture of LHRH and NiCl2
in positive (a) and negative (b) ion modes. R 5 CH2O.
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another origin for the much higher intensities observed
for the synthesized complex. Thus, at least the differ-
ence in abundance of the LHRH–metal ions between
both experiments can be attributed to the desorption of
intact complexes.
Experiments with Cu
Figure 3 shows the spectra obtained from the
LHRH–Cu complex and Figure 4 the spectra from a
mixture of the apopeptide with CuCl2. In positive ion
mode the copper-containing species [M 1 Cu]1 was
detected for both samples. It was much more abundant
for the synthetic complex (Figure 3a) than for the
mixture (Figure 4a) where [M 1 H]1 was the major ion
detected. In negative mode the same kind of behavior
was observed. The [M 2 2H 1 Cu]2 species was also
detected in both cases, but with much higher relative
intensity in the case of the synthesized complex (com-
pare Figures 3b and 4b).
As we have argued in the case of Ni and Zn, at least
the difference in intensity of the complex ion in both
experiments can be attributed to the desorption of
preformed ions. For copper, the contribution of plume
reactions is nevertheless more significant than for the
two other metals, despite the greater stability of the
Cu(II)–LHRH complex in solution. The peptide–metal
salt mixtures were prepared with Cu(II)Cl2. As opposed
to Ni and Zn, copper mainly appeared as Cu(I) in both
samples and in both polarities, i.e., [M 1 Cu(I)]1 and
[M 2 2H 1 Cu(I)]2. The reduction of copper from
Cu(II) to Cu(I) has already been observed in other
MALDI experiments [19]. These authors stated that the
origin of the Cu(I) ion is unknown, but it was tentatively
attributed to the photochemical reduction of Cu(II).
In the case of the synthesized LHRH–Cu complex,
the isotopic distribution of the peak assigned as [M 1
Cu]1 showed a Cu(II) contribution besides Cu(I). Figure
5a, b show the calculated isotopic distributions which
should be observed from [M 2 H 1 Cu(II)]1 and [M 1
Cu(I)]1, respectively. Figure 5c shows the theoretical
pattern for 25% of Cu(II) and 75% Cu(I), along with the
observed spectrum. A Cu(II) contribution is detected in
negative mode as well. The [M 2 3H 1 Cu(II)]2 ion
accounts for approximately 40% of the total complex
intensity. Cu(II)-containing ions were hardly detected
in the case of the mixture (see insets Figure 4). Most of
the copper must therefore be reduced during the
MALDI process. It is, however, unclear whether the
copper is reduced prior to reacting with the apopeptide
in the plume, or if the desorbed Cu(II) complex under-
goes a reduction by capturing a hydrogen atom. The
very high abundance of the Cu(I)-containing species in
the case of the synthesized complex compared to the
mixture suggests a reduction of the desorbed complex.
In the negative ion spectrum of the synthetic com-
plex, higher order adducts of Cu(I) to the complex are
detected. [M 2 4H 1 Cu(II) 1 Cu(I)]1 and [M 2
Figure 3. MALDI FTMS spectra of the LHRH–Cu complex in
positive (a) and negative (b) ion modes (insets: isotopic distribu-
tions). R 5 CH2O.
Figure 4. MALDI FTMS spectra of a mixture of LHRH and CuCl2
in positive (a) and negative (b) ion modes. No Cu(II) complexes
are evident from the isotopic patterns (insets). R 5 CH2O.
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3H 1 2Cu(I)]2 whose isotopic distributions overlap are
particularly intense. The fact that higher order adducts
are formed by addition of Cu(I) only [and not Cu(II)]
suggests that Cu(I) is the reactive species in the plume
and that the Cu(II) complex is likely to be desorbed
intact from the solid phase. The same behavior has
previously been observed in the case of the adrenocor-
ticotropic fragment 4–11 [20].
Isotopic patterns resulting from Ni and Zn were also
inspected. These did correctly fit the theoretical distri-
butions, and there was no evidence for more than one
oxidation state.
Experiments with Ag(I)
Mixture of the peptide with a silver salt. In order to
further distinguish the addition of Cu(I) in the plume
from the desorption and subsequent reduction of pre-
formed LHRH–Cu(II) complexes, we performed control
experiments in which the copper salt was replaced by a
silver salt. Ag(I) was chosen because, like Cu(I), it has a
d10 electron shell and its behavior should be very
similar to that of Cu(I), the main difference being their
ionic radii [21]. Moreover, unlike copper, silver is not
expected to from stable complexes with the peptide in
solution. Ag adducts to the peptide should thus arise
only from plume reactions.
When Ag(I) is mixed with the apopeptide, the [M 1
Ag]1 ion is detected in the positive ion spectrum (see
Figure 6a). In negative ion mode, the Ag adduct to the
peptide [M 2 2H 1 Ag]2 is detected with low relative
abundance together with its fragment at m/z 1257 which
results from the loss of the serine side chain (CH2O) (see
Figure 6b). These spectra show the same features as those
obtained from the mixture with a copper(II) salt (compare
Figures 4 and 6). This lends additional support to the
interpretation that the copper-containing species ([M 1
Cu]1, [M 2 2H 1 Cu]2) detected for the LHRH–Cu and
the LHRH mixture with a copper salt originate from
plume reactions of Cu(I) with the peptide.
In the case of copper, we have seen that a very high
signal of [M 1 Cu]1 and [M 2 2H 1 Cu]2 is detected
upon laser desorption of samples prepared with the
synthetic metal complex. This signal is much more
intense than the one detected for the mixture. The same
observation holds if we compare the [M 1 Ag]1 signal
of the mixture with the silver salts (Figure 6) and the
[M 1 Cu]1 signal from the synthesized complex (Fig-
ure 3). To account for that, we must assume that not
only Cu(II)-containing species are formed by direct
desorption, but that some Cu(II) complex ions are
subsequently reduced in the MALDI plume, e.g., by
capturing a hydrogen atom left by the matrix. Hence,
there is a nonnegligible contribution of preformed com-
plex ions to the overall signal for the LHRH–Cu com-
plex, and these ions can be detected as Cu(II) species or
reduced to Cu(I) species.
Competition experiment with Ag. The similar gas-phase
reactivity of Ag(I) and Cu(I), and the fact that Ag does
not form a stable complex with LHRH stimulated us to
consider competition experiments with the synthetic
complexes. Competition between Ag(I) and Cu(II)
would give very complicated spectra in which direct
Figure 5. Isotopic distributions expected for (a) pure [M 2 H 1
Cu(II)]1, (b) pure [M 1 Cu(I)]1, and (c) a 25:75 mixture of both
species with, overlaid, the experimentally observed distribution of
the synthetic LHRH–Cu complex.
Figure 6. MALDI FTMS spectra of a mixture of LHRH and
CF3COOAg recorded in positive (a) and negative (b) ion modes.
R 5 CH2O.
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absorption of Cu complexes as well as cationization by
Cu(I) or Ag(I) in the plume all contribute to the detected
species. Hence, the competition experiments were car-
ried out with silver and nickel because we have shown
that the contribution to the complex ion signal from
plume reactions with Ni(II) is very weak compared to
the intact desorption of complex. In the following
experiments, Ni complexes result from intact desorp-
tion, whereas Ag adducts result from plume reactions.
Figure 7a, b show the positive and negative ion
spectra obtained from a mixture of the LHRH–Ni
complex and 1 molar equivalent of CF3COOAg in PNA.
We have seen above that when Ag(I) is present with the
apopeptide, it reacts to form an abundant [M 1 Ag]1
peak in positive ion mode (see Figure 6a). For the
mixture of the silver salt with the LHRH–Ni complex,
however, the [M 1 Ag]1 peak is hardly detected, and
the spectrum is dominated by the [M 1 H]1 ion and the
LHRH–Ni complex fragment at [y8 1 Ni]
1 (see Figure
7a). This shows that the [M 1 H]1 ion does not origi-
nate from protonation of the free peptide because it
would also react with the silver. The complex is thus
shown to survive the deposition in the matrix solid
phase. In addition, this demonstrates that the [M 1 H]1
peak is indeed a fragment from the metal complex. In
negative ion mode, the same kind of results are ob-
tained, and the spectrum looks very much like the one
obtained without the silver salt (compare Figures 6b
and 7b). This confirms that in the case of the Ni–LHRH
complex, the contribution to the [M 2 H 1 Ni]1 signal
from plume reactions is almost negligible.
When the sample is prepared by mixing the apopep-
tide with a solution containing both Ni(NO3)2 and
CF3COOAg in proportion 1:1:1 prior to adding the
matrix, the spectra (see Figure 8) are very different than
the ones obtained for the synthetic complex. In positive
ion mode, a peak of Ag cationized peptide appears
together with an intense protonated peptide ion. In the
negative ion mode, the major species detected are [M 2
H 2 CH2O]
2, [M 2 H]2, and Ag adducts to the pep-
tide. These spectra look very similar to those obtained
when mixing the apopeptide with only the silver salt.
We observe that for the mixture of the peptide with the
two salts, the free peptide is desorbed and reacts with
the silver in the plume. The fact that no Ni complexes
are detected confirms that those which are observed for
the synthetic complex are not formed in the plume but
must emerge from the solid phase during the laser
desorption process.
Our interpretation of these findings is that the diva-
lent metal complexes of LHRH preferably form nega-
tive ions by multiple deprotonation of the peptide
chain, presumably at amide nitrogens. This in turn
produces a large amount of protons which can attack
the metal binding site of other LHRH molecules, dis-
rupting the complex and causing the [M 1 H]1 species
to be so abundant in positive mode.
Figure 7. MALDI FTMS spectra of a mixture of LHRH–Ni
complex and CF3COOAg recorded in (a) and negative (b) ion
modes. R 5 CH2O.
Figure 8. MALDI FTMS spectra of a mixture of LHRH,
Ni(NO3)2, and CF3COOAg in a 1:1:1 molar ratio in positive (a) and
negative (b) ion modes. R 5 CH2O.
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Conclusion
This work using LHRH–metal complexes as model
compounds clearly shows that metal complexes of
biomolecules can survive the MALDI sample prepara-
tion and the laser desorption/ionization step if a non-
acidic matrix is used. In the case of Cu, a significant
contribution from plume reactions was found, but for
Ni and Zn, we have shown that under the conditions
used throughout this work, there is negligible cation-
ization in the plume. The plume reactions in the case of
copper can be attributed to the addition of Cu(I) to the
free peptide. Moreover, desorption of LHRH–Cu(II)
complexes and subsequent reduction to LHRH–Cu(I)
must also occur to account for the very intense signal of
the [M 1 Cu(I)]1 and [M 2 2H 1 Cu(I)]2 signals de-
tected in the case of the synthetic complex.
We have shown as well that negative ion spectra are
very useful because the complex anions were found to
be of high relative abundance. This is probably the
result of the high acidity of the amide NH groups of the
complex in the gas phase. In the case of mixtures of the
apopeptide with metal ion salts, intact complex ions are
hardly detected in most cases.
It is important to stress that in order to be detected,
the complex must be present in the sample at high
concentrations compared to the apopeptide. Otherwise,
the risk of detecting nonspecific adducts is very high.
Thus, the mixture of metal salt with peptides does not
always represent a reliable procedure for the prepara-
tion of samples for the MALDI analysis of metal–
peptide complexes. A reason for this may be the com-
plexing ability of the matrix itself [22] which can
prevent the formation of the peptide complex.
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